Q2 2024 · 13F-HR
NEA Management Company, LLCholdings as filed
Filed 2024-08-14 · accession 0001012975-24-000337
$1.33B
Reported value
41
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $206.7M | 15.6% | 3,745,262 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $160.0M | 12.0% | 4,572,810 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $119.5M | 8.99% | 2,909,956 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $98.6M | 7.42% | 24,471,264 | Common | SOLE |
| 22266M104 | COUR | COURSERA INC | $92.1M | 6.93% | 12,867,769 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $85.8M | 6.45% | 1,587,854 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $80.8M | 6.08% | 5,584,753 | Common | SOLE |
| 65345N106 | NN | NEXTNAV INC | $66.4M | 5.00% | 8,189,156 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $36.9M | 2.78% | 1,090,793 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $33.9M | 2.55% | 11,370,376 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $28.8M | 2.16% | 7,692,298 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $28.4M | 2.14% | 2,370,542 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $22.7M | 1.71% | 3,969,834 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $21.1M | 1.59% | 3,568,781 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS INC | $20.7M | 1.56% | 4,448,757 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $20.5M | 1.54% | 1,250,001 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $20.2M | 1.52% | 1,960,169 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $16.7M | 1.25% | 17,079,778 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $16.3M | 1.23% | 18,093,034 | Common | SOLE |
| 10920V404 | — | NEUEHEALTH INC | $14.8M | 1.12% | 2,726,917 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $11.8M | 0.89% | 2,776,409 | Common | SOLE |
| 75915K200 | — | REGULUS THERAPEUTICS INC | $11.6M | 0.87% | 6,467,802 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $10.9M | 0.82% | 2,437,689 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $10.6M | 0.80% | 1,500,000 | Common | SOLE |
| 12430A300 | BZFD | BUZZFEED INC | $10.6M | 0.80% | 3,833,473 | Common | SOLE |
| 628988107 | MYND | MYND AI INC | $10.1M | 0.76% | 3,642,711 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $8.9M | 0.67% | 1,713,720 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $8.7M | 0.65% | 14,986,793 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $7.2M | 0.54% | 4,785,494 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $6.8M | 0.51% | 2,000,275 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $6.1M | 0.46% | 6,147,260 | Common | SOLE |
| 25058X303 | DM* | DESKTOP METAL INC | $5.9M | 0.45% | 1,439,892 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $5.8M | 0.44% | 1,071,428 | Common | SOLE |
| 90114C107 | TUYA | TUYA INC | $5.6M | 0.42% | 3,260,976 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $4.4M | 0.33% | 2,922,772 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $4.4M | 0.33% | 1,462,586 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $4.0M | 0.30% | 2,382,286 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED NV | $2.4M | 0.18% | 442,649 | Common | SOLE |
| 81726A100 | — | SENTI BIOSCIENCES INC | $1.2M | 0.09% | 4,426,151 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $940,583 | 0.07% | 570,050 | Common | SOLE |
| 96328L205 | 2CH | WHEELS UP EXPERIENCE INC | $200,576 | 0.02% | 106,125 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.